Ressources résidentielles Le Service des ressources résidentielles en santé mentale s'adresse aux adultes (incluant les personnes âgées) qui souffrent de troubles mentaux, qui ne peuvent vivre de façon autonom

Since its creation in 1986, the Eating Disorders Program (EDP) has offered specialized clinical services for people 18 years and older who suffer from anorexia nervosa or bulimia nervosa.

Research at the Eating Disorders Program addresses various aspects of the phenomenology, etiology, and treatment of eating disorders in the spectrum of anorexia nervosa and bulimia nervosa.

Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

The Psychotic Disorders Program at the Douglas Institute provides services to adults aged 18 to 65 with schizophrenia or other forms of psychoses, with the exception of the Prevention and Early Intervention Program for Psychoses (PEPP-Montréal), which is designed for people aged 14 to 30.

The Geriatric Psychiatry Program at the Douglas Institute provides services to clients aged 65 and older and to adults younger than 65 with a geriatric profile. The program covers psychiatric diagnoses such as: mood disorders anxiety di

The Severe Disruptive Disorders Program offers a range of superspecialized services for children aged 6 to 12 years with behaviour problems with or without an attention deficit disorder / hyperactivity disorder (ADHD).

Mental Illness: The Facts and the Fiction The theme of the 2009 Session of Mini-Psych is Mental Illness: The Facts and the Fiction. Each of the 6 classes given by an expert from the Douglas Institute is exploring the

Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.

Cognitive remediation is a computer-assisted therapy that promotes the stimulation of cognitive skills necessary for everyday life. Many studies have shown this therapy to have a measurable impact on cognitive deficits related to dementia, making it an invaluable intervention tool in the treatment of Alzheimer's disease.